Table 1.
Study characteristics
| Programme | Evaluation methods used | Countries |
|---|---|---|
|
Measles eradication[10,17] |
Semi-structured interviews with key informants (national, regional, district and facility levels) |
Bangladesh, Brazil, Cameroon, Ethiopia, Tajikistan, Viet Nam |
| Reviews of secondary documents | ||
|
New vaccine introduction |
Semi-structured interviews with key informants (national, regional and district levels) |
Cameroon Ethiopia Guatemala Kenya Rwanda, Mali |
|
PCV |
Questionnaire with health facility staff |
|
|
Rotavirus |
Routine health service use data |
|
|
HPV | ||
|
Meningitis A[11] | ||
|
Polio eradication[12] |
Semi-structured interviews with key informants (national, district and community levels) |
Nepal, India, Pakistan, Nigeria, Ethiopia, Rwanda, Angola |
| Participant observation in polio campaigns, surveillance, and routine health post activities | ||
| Reviews of documents | ||
| Routine health service use data | ||
| DPT3 coverage data from DHS and IHME | ||
| Attended births and antenatal care coverage data from DHS |
PCV = pneumococcal conjugate vaccine; rotavirus = rotavirus vaccine; HPV = human papillomavirus vaccine; Meningitis A = Meningitis A vaccine.